| Title | Research Area | Implementing Organisations | Funding Organisations | Start Year | Status |
|---|---|---|---|---|---|
| Multi-dimensional research to enable systems medicine: Acceleration using a cluster approach' at Kalyani, West Bengal | Medical Sciences | Tata Medical Center (TMC), Kolkata | Department of Biotechnology (DBT) | 2017 | Completed |
| Rapid diagnosis of mycobacterial infections (M tuberculosis & non-tubercular mycobacteria (NTM) in HIV positive and HIV negative patients with ocular tuberculosis | Medical Sciences | Department of Biochemistry, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012 | Department of Biotechnology (DBT) | 2017 | Completed |
| A Novel Strategy for Developing Combination Therapy for Malari | Medical Sciences | National Institute of Malaria Research (NIMR), New Delhi | Department of Biotechnology (DBT) | 2017 | Completed |
| Role of human cathelicidine in gastric carcinogenesis | Medical Sciences | Indian Institute of Technology (IIT), Mandi, Himachal Pradesh | Department of Biotechnology (DBT) | 2017 | Completed |
| Prediction of treatment failure among diabetic patients with tuberculosis by peripheral blood transcriptional signature | Medical Sciences | National Institute for Research in Tuberculosis (NIRT) | Department of Biotechnology (DBT) | 2017 | Completed |
| Insights into the modulation of adaptive and innate immune responses by myeloid-derived suppressor cells during chronic HBV infection | Medical Sciences | Institute of Postgraduate Medical Education and Research (IPGMER), Kolkata | Department of Biotechnology (DBT) | 2017 | Completed |
| Investigation of mechanisms of emerging drug resistance in Trichophyton sp., the major causative agents of fungal skin infections | Medical Sciences | University College of Medical Sciences & GTB Hospital (UCMC), New Delhi | Department of Biotechnology (DBT) | 2017 | Completed |
| Proteomic analysis of severe and non-severe vivax malaria from different endemic areas of India to identify diagnostic and prognostic markers; and correlate host responses with disease severity | Medical Sciences | Indian Institute of Technology (IIT) | Department of Biotechnology (DBT) | 2017 | Completed |
| A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis | Medical Sciences | All India Institute of Medical Sciences (AIIMS) | Gilead Sciences, Inc., USA | 2017 | Completed |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) | Medical Sciences | All India Institute of Medical Sciences (AIIMS) | Gilead Sciences, Inc., USA | 2017 | Completed |
Accessibility Controls